ECSP099507A - Método para determinar la estabilidad de metilenaminas orgánicas en presencia de amina oxidasa sensible a semicarbazida - Google Patents

Método para determinar la estabilidad de metilenaminas orgánicas en presencia de amina oxidasa sensible a semicarbazida

Info

Publication number
ECSP099507A
ECSP099507A EC2009009507A ECSP099507A ECSP099507A EC SP099507 A ECSP099507 A EC SP099507A EC 2009009507 A EC2009009507 A EC 2009009507A EC SP099507 A ECSP099507 A EC SP099507A EC SP099507 A ECSP099507 A EC SP099507A
Authority
EC
Ecuador
Prior art keywords
stability
determining
sensitive
oxidase
semicarbazida
Prior art date
Application number
EC2009009507A
Other languages
English (en)
Inventor
Michael Angelastro
Adedayo Adedoyin
Julie Ann Bick
Jennifer Cairns
Yongqing Huang
Guyan Liang
Heng-Keang Lim
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ECSP099507A publication Critical patent/ECSP099507A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona métodos para determinar la estabilidad de metilenamina, compuestos similares a metilenamina o compuestos que contienen un resto metilenamina en presencia de amina oxidasa sensible a semicarbazida (SSAO) o una muestra biológica que contiene actividad de SSAO. Los métodos descritos se pueden configurar en un formato de ensayo para aplicaciones de selección de alto rendimiento.
EC2009009507A 2007-01-10 2009-07-09 Método para determinar la estabilidad de metilenaminas orgánicas en presencia de amina oxidasa sensible a semicarbazida ECSP099507A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88426307P 2007-01-10 2007-01-10

Publications (1)

Publication Number Publication Date
ECSP099507A true ECSP099507A (es) 2009-08-28

Family

ID=39361382

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009507A ECSP099507A (es) 2007-01-10 2009-07-09 Método para determinar la estabilidad de metilenaminas orgánicas en presencia de amina oxidasa sensible a semicarbazida

Country Status (29)

Country Link
US (3) US20100028895A1 (es)
EP (1) EP2121964A1 (es)
JP (2) JP2010515461A (es)
KR (1) KR20090107533A (es)
CN (1) CN101578375B (es)
AR (1) AR064776A1 (es)
AU (1) AU2008204923A1 (es)
BR (1) BRPI0806321A2 (es)
CA (1) CA2674704A1 (es)
CR (1) CR10862A (es)
DO (1) DOP2009000175A (es)
EC (1) ECSP099507A (es)
GT (1) GT200900199A (es)
HN (1) HN2009001289A (es)
IL (1) IL199707A0 (es)
MA (1) MA31226B1 (es)
MX (1) MX2009005962A (es)
MY (1) MY152893A (es)
NI (1) NI200900132A (es)
NO (1) NO20092816L (es)
NZ (1) NZ578079A (es)
RU (1) RU2009130380A (es)
SG (1) SG177920A1 (es)
SV (1) SV2009003327A (es)
TN (1) TN2009000232A1 (es)
TW (1) TW200907065A (es)
UA (1) UA103300C2 (es)
WO (1) WO2008086325A1 (es)
ZA (1) ZA200903897B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100533911B1 (ko) 1997-05-23 2005-12-06 바이오티에 세라피스 코포레이션 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
JP4499918B2 (ja) * 1998-03-27 2010-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高スループット・スクリーニング用の小型化マイクロタイタ・プレート
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
EP1362120A1 (en) 2001-02-23 2003-11-19 Biovitrum Ab Method for purification of soluble ssao

Also Published As

Publication number Publication date
MY152893A (en) 2014-11-28
MX2009005962A (es) 2009-06-15
AU2008204923A1 (en) 2008-07-17
HK1137784A1 (en) 2010-08-06
TW200907065A (en) 2009-02-16
EP2121964A1 (en) 2009-11-25
BRPI0806321A2 (pt) 2011-09-06
KR20090107533A (ko) 2009-10-13
US20130071870A1 (en) 2013-03-21
TN2009000232A1 (en) 2010-10-18
MA31226B1 (fr) 2010-03-01
GT200900199A (es) 2010-04-13
NO20092816L (no) 2009-08-10
CR10862A (es) 2009-08-12
WO2008086325A1 (en) 2008-07-17
SV2009003327A (es) 2010-02-05
RU2009130380A (ru) 2011-02-20
JP2014204727A (ja) 2014-10-30
WO2008086325A8 (en) 2009-07-16
NI200900132A (es) 2010-03-01
AR064776A1 (es) 2009-04-22
US20100028895A1 (en) 2010-02-04
US8883410B2 (en) 2014-11-11
JP2010515461A (ja) 2010-05-13
HN2009001289A (es) 2013-02-11
UA103300C2 (ru) 2013-10-10
NZ578079A (en) 2013-02-22
IL199707A0 (en) 2010-04-15
US20140363836A1 (en) 2014-12-11
DOP2009000175A (es) 2009-07-31
CN101578375B (zh) 2012-11-07
CN101578375A (zh) 2009-11-11
SG177920A1 (en) 2012-02-28
ZA200903897B (en) 2010-04-28
CA2674704A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
BRPI0710054B8 (pt) métodos para identificar um ou uma pluralidade de metabólitos celulares, para triar um composto de teste, e, para testar um composto de teste
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
CR10612A (es) Anticuerpo especifico prlr y sus usos
BRPI0807392A2 (pt) Método de cálculo de um plano de desenvolvimento para pelo menos uma parte de um campo contendo um recurso subterrâneo, e mídia passível de leitura por computador codificada com um programa de computador para cálculo de um plano de desenvolvimento para pelo menos uma parte de um campo contendo um recurso subterrâneo.
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
AR053251A1 (es) Estrategias nuevas de etiquetado para la deteccion sensible de analitos
AR067755A1 (es) Sistema detector microfluidico o articulo para estudiar una muestra que contiene un analito
BRPI0820721A2 (pt) Reagentes e métodos para detectar analitos
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
CL2009001488A1 (es) Metodo para tratar una muestra liquida que contiene particulas microbiologicas.
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
DE602007013080D1 (de) Isotopenmarkiertes einfangmittel und verfahren zur identifizierung reaktiver metaboliten
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
FI20051330L (fi) Menetelmä navigointitietojen virheiden havaitesemiseksi
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
MX2012000041A (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
AR064467A1 (es) Derivados de antraquinona como sustancias marcadoras para liquidos
ECSP099507A (es) Método para determinar la estabilidad de metilenaminas orgánicas en presencia de amina oxidasa sensible a semicarbazida
BR112016006955A2 (pt) compostos de marcação e seu uso em ensaios
UY29918A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
ATE514082T1 (de) Biologischer bodendetektor
HN2011001773A (es) Compuestos etanaminicos y su uso para tratar la depresion nuevo titulo técnico: compuestos etanamínicos y composición farmacéutica que los contiene para la depresion. (a petición de la oficina)